drugset / Trial / NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Phase 4
Terminated
41 enrolled
Pharmatech
Manyak, Michael, M.D. · collabWatson Pharmaceuticals · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This research study looks at Testosterone levels in patients receiving Trelstar versus those receiving Lupron or Zoladex. These drugs have been approved for treatment of Prostate Cancer by the FDA.
Timeline
- Start
- 2002-09
- Primary completion
- 2006-05
- Completion
- 2006-07
Outcome
Outcome not reported
Stopped (Business): “Withdrawal of funding support”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decapeptyl | Unknown | — | — |
| Comparator | Goserelin | Other / unclassified | — | — |
| Comparator | Leuprolide | Other / unclassified | — | — |